Chlamydia Tests-Medical Devices Pipeline Assessment, 2017

Chlamydia Tests-Medical Devices Pipeline Assessment, 2017


  • Products Id :- GDME0343EPD
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Chlamydia Tests-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Chlamydia Tests-Medical Devices Pipeline Assessment, 2017" provides an overview of Chlamydia Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Chlamydia Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Chlamydia Tests under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Chlamydia Tests and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Chlamydia Tests under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Chlamydia Tests Overview 5

3 Products under Development 6

3.1 Chlamydia Tests-Pipeline Products by Stage of Development 6

3.2 Chlamydia Tests-Pipeline Products by Territory 7

3.3 Chlamydia Tests-Pipeline Products by Regulatory Path 8

3.4 Chlamydia Tests-Pipeline Products by Estimated Approval Date 9

4 Chlamydia Tests-Pipeline Products under Development by Companies 10

4.1 Chlamydia Tests Companies-Pipeline Products by Stage of Development 10

4.2 Chlamydia Tests-Pipeline Products by Stage of Development 11

5 Chlamydia Tests Companies and Product Overview 12

5.1 Beckman Coulter Inc Company Overview 12

5.1.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 bioMerieux S.A. Company Overview 13

5.2.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 13

5.3 Boditech Med Inc Company Overview 14

5.3.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.4 DiaSorin S.p.A Company Overview 15

5.4.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 15

5.5 Ellume Company Overview 18

5.5.1 Ellume Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Genome Diagnostics Pvt. Ltd. Company Overview 19

5.6.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 19

5.7 Molbio Diagnostics Pvt. Ltd. Company Overview 20

5.7.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

5.8 ProCelo AS Company Overview 21

5.8.1 ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview 21

5.9 Queensland University of Technology Company Overview 22

5.9.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 22

5.10 Quidel Corp Company Overview 23

5.10.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 23

5.11 Sansure Biotech Inc Company Overview 24

5.11.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

6 Chlamydia Tests-Recent Developments 25

6.1 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 25

6.2 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 25

6.3 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 27

6.4 May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 28

6.5 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 29

6.6 Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 31

6.7 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 33

6.8 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 34

6.9 Apr 20, 2017: bioMerieux-First-Quarter 2017 Business Review 34

6.10 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 37

6.11 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 38

6.12 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 42

6.13 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 44

6.14 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 45

6.15 Mar 09, 2017: Alere Provides Update on Arriva Medical 45

6.16 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 45

6.17 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 47

6.18 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 48

6.19 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 50

6.20 Jan 19, 2017: bioMerieux-Fourth-Quarter 2016 Business Review 50

6.21 Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification 52

6.22 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 53

6.23 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 53

6.24 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 54

6.25 Jan 04, 2017: Alere Provides Update on Arriva Medical 54

6.26 Dec 28, 2016: Alere Provides Update on Arriva Medical 55

6.27 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 56

6.28 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 56

6.29 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 57

6.30 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 57

6.31 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings 57

6.32 Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results 59

6.33 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016 61

6.34 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 62

6.35 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 62

6.36 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 63

6.37 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 65

6.38 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 66

6.39 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 68

6.40 Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance 70

6.41 Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard 72

6.42 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 72

6.43 Aug 31, 2016: bioMerieux-First-Half 2016 Results 73

6.44 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 77

6.45 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings 78

6.46 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 79

6.47 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 81

6.48 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 83

6.49 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 87

6.50 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results 87

6.51 Jul 28, 2016: Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance 88

6.52 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 90

6.53 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results 92

6.54 Jul 18, 2016: bioMerieux-Second-Quarter 2016 Business Review 93

7 Appendix 97

7.1 Methodology 97

7.2 About GlobalData 100

7.3 Contact Us 100

7.4 Disclaimer 100

1.2 List of Figures

Figure 1: Chlamydia Tests-Pipeline Products by Stage of Development 6

Figure 2: Chlamydia-Pipeline Products by Territory 7

Figure 3: Chlamydia Tests-Pipeline Products by Regulatory Path 8

Figure 4: Chlamydia Tests-Pipeline Products by Estimated Approval Date 9

1.1 List of Tables

Table 1: Chlamydia Tests-Pipeline Products by Stage of Development 6

Table 2: Chlamydia Tests-Pipeline Products by Territory 7

Table 3: Chlamydia Tests-Pipeline Products by Regulatory Path 8

Table 4: Chlamydia Tests-Pipeline Products by Estimated Approval Date 9

Table 5: Chlamydia Companies-Pipeline Products by Stage of Development 10

Table 6: Chlamydia Tests-Pipeline Products by Stage of Development 11

Table 7: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: Diagnostic Test-Chlamydia-Product Status 12

Table 9: Diagnostic Test-Chlamydia-Product Description 12

Table 10: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 13

Table 11: NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Status 13

Table 12: NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Description 13

Table 13: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 14: AFIAS-6 Chlamydia-Product Status 14

Table 15: AFIAS-6 Chlamydia-Product Description 14

Table 16: DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 15

Table 17: LIAISON-Chlamydia P. IgA Assay-Product Status 15

Table 18: LIAISON-Chlamydia P. IgA Assay-Product Description 15

Table 19: LIAISON-Chlamydia P. IgG Assay-Product Status 16

Table 20: LIAISON-Chlamydia P. IgG Assay-Product Description 16

Table 21: LIAISON XL-Chlamydia Pneumoniae Assay-Product Status 16

Table 22: LIAISON XL-Chlamydia Pneumoniae Assay-Product Description 17

Table 23: Ellume Pipeline Products & Ongoing Clinical Trials Overview 18

Table 24: ESP-Based Diagnostic Test-Chlamydia-Product Status 18

Table 25: ESP-Based Diagnostic Test-Chlamydia-Product Description 18

Table 26: Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 27: Chlamydia trachomatis Real Time PCR Kit-Product Status 19

Table 28: Chlamydia trachomatis Real Time PCR Kit-Product Description 19

Table 29: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20

Table 30: Truenat Chlamydia Assay-Product Status 20

Table 31: Truenat Chlamydia Assay-Product Description 20

Table 32: ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview 21

Table 33: Diagnostic Kit-Chlamydia Pneumonia-Product Status 21

Table 34: Diagnostic Kit-Chlamydia Pneumonia-Product Description 21

Table 35: Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 22

Table 36: Chlamydia-induced Infertility Diagnostic Assay-Product Status 22

Table 37: Chlamydia-induced Infertility Diagnostic Assay-Product Description 22

Table 38: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Table 39: IsoAmp Assay-Chlamydia Trachomatis-Product Status 23

Table 40: IsoAmp Assay-Chlamydia Trachomatis-Product Description 23

Table 41: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 42: Chlamydia Pneumoniae DNA Fluorescence Diagnostic Kit-Product Status 24

Table 43: Chlamydia Pneumoniae DNA Fluorescence Diagnostic Kit-Product Description 24

Table 44: Glossary 99

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Beckman Coulter Inc, bioMerieux S.A., Boditech Med Inc, DiaSorin S.p.A, Ellume, Genome Diagnostics Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., ProCelo AS, Queensland University of Technology, Quidel Corp, Sansure Biotech Inc

Beckman Coulter Inc, Diagnostic Test-Chlamydia; bioMerieux S.A., NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test; Boditech Med Inc, AFIAS-6 Chlamydia; DiaSorin S.p.A, LIAISON-Chlamydia P. IgA Assay; DiaSorin S.p.A, LIAISON-Chlamydia P. IgG Assay; DiaSorin S.p.A, LIAISON XL-Chlamydia Pneumoniae Assay; Ellume, ESP-Based Diagnostic Test-Chlamydia; Genome Diagnostics Pvt. Ltd., Chlamydia trachomatis Real Time PCR Kit; Molbio Diagnostics Pvt. Ltd., Truenat Chlamydia Assay; ProCelo AS, Diagnostic Kit-Chlamydia Pneumonia; Queensland University of Technology, Chlamydia-induced Infertility Diagnostic Assay; Quidel Corp, IsoAmp Assay-Chlamydia Trachomatis; Sansure Biotech Inc, Chlamydia Pneumoniae DNA Fluorescence Diagnostic Kit

select a license

Single User License
USD 2500 INR 162625
Site License
USD 5000 INR 325250
Corporate User License
USD 7500 INR 487875

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com